Hermes lands FDA clearance for Affinity

By staff writers

February 18, 2020 -- Swedish nuclear medicine software developer Hermes Medical Solutions has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Affinity viewing and analysis software for molecular imaging and nuclear medicine exams.

Affinity features fast loading of images, the firm's Deep Fusion visualization technology, and artificial intelligence (AI)-driven workflows, according to the vendor. Its user interface was created by developers from the gaming industry, Hermes said.

Affinity had previously been cleared by Health Canada and received the CE Mark.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking